A major grocery chain operator has agreed to pay a multimillion-dollar settlement after coming under scrutiny for pricing practices tied to one of its business segments.
The case centers not on what shoppers paid at checkout, but on allegations involving how certain prices were reported behind the scenes.
Federal officials say prescription price reporting practices caused government health care programs to pay more than they should have, resulting in a settlement worth tens of millions of dollars.
The case highlights how prescription pricing disclosures can affect taxpayer-funded health care spending, even when consumers receive discounted pharmacy prices.
Ahold Delhaize agrees to $40M settlement over prescription price data
Ahold Delhaize USA (ADRNY) has agreed to pay $40 million to resolve allegations that it submitted inflated prescription drug pricing data to…



